Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cost effectiveness analysis in health care: contraindications.

Literature DB >> 12386045

Cost effectiveness analysis in health care: contraindications.

Cam Donaldson¹, Gillian Currie, Craig Mitton.

Abstract

Mesh：

Year: 2002 PMID： 12386045 PMCID： PMC1124387 DOI： 10.1136/bmj.325.7369.891

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

23 in total

Review 1. Twenty years of health care economic analysis in Spain: are we doing well?

Authors: A García-Altés
Journal: Health Econ Date: 2001-12 Impact factor: 3.046

Review 2. Economics notes: types of economic evaluation.

Authors: S Palmer; S Byford; J Raftery
Journal: BMJ Date: 1999-05-15

3. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.

Authors: K Kerlikowske; P Salzmann; K A Phillips; J A Cauley; S R Cummings
Journal: JAMA Date: 1999-12-08 Impact factor: 56.272

4. Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance.

Authors: C Donaldson; V Hundley; E McIntosh
Journal: Health Econ Date: 1996 May-Jun Impact factor: 3.046

5. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Authors: M F Drummond; T O Jefferson
Journal: BMJ Date: 1996-08-03

6. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis.

Authors: H B El-Serag; J M Inadomi; K V Kowdley
Journal: Ann Intern Med Date: 2000-02-15 Impact factor: 25.391

7. Two view mammography at incident screens: cost effectiveness analysis of policy options.

Authors: K Johnston; J Brown
Journal: BMJ Date: 1999-10-23

8. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

Authors: A Gafni; S Birch
Journal: CMAJ Date: 1993-03-15 Impact factor: 8.262

9. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.

Authors: M K Gould; A D Dembitzer; G D Sanders; A M Garber
Journal: Ann Intern Med Date: 1999-05-18 Impact factor: 25.391

10. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

Authors: D B Mark; M A Hlatky; R M Califf; C D Naylor; K L Lee; P W Armstrong; G Barbash; H White; M L Simoons; C L Nelson
Journal: N Engl J Med Date: 1995-05-25 Impact factor: 91.245

25 in total

Cost effectiveness analysis in health care: contraindications.

Review 1. Twenty years of health care economic analysis in Spain: are we doing well?

Review 2. Economics notes: types of economic evaluation.

3. Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness.

4. Using economics alongside clinical trials: why we cannot choose the evaluation technique in advance.

5. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

6. Screening for hereditary hemochromatosis in siblings and children of affected patients. A cost-effectiveness analysis.

7. Two view mammography at incident screens: cost effectiveness analysis of policy options.

8. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

9. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis.

10. Cost effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction.

1. How to change clinical behaviour: no answers yet.

2. Efforts to ban direct-to-consumer advertising in New Zealand: a call to action.

3. Confidentiality: consent is not sufficient.

4. Using discrete choice experiments within a cost-benefit analysis framework: some considerations.

5. Cost-effectiveness of a multifaceted intervention to improve quality of osteoporosis care after wrist fracture.

Review 6. Approach to economic evaluation in primary care: review of a useful tool for primary care reform.

7. A decision-theoretic framework for the application of cost-effectiveness analysis in regulatory processes.

8. Decision Analysis and Cost-effectiveness Analysis.

9. Cost-effectiveness of an intervention to reduce emergency re-admissions to hospital among older patients.

10. Cost-effectiveness of a telephone-delivered intervention for physical activity and diet.